Wasdell gets serialisation-ready ahead of EU and US deadlines

By Staff Reporter

- Last updated on GMT

(Image: Getty/fotojog)
(Image: Getty/fotojog)
Wasdell Group has launched a serialisation service, with optional three-tier aggregation, ahead of EU and US implementation deadlines.

UK-headquartered Wasdell – which offers pharmaceutical and clinical research manufacturing, packaging, technical, and distribution services – has announced a serialisation offering to comply with the Falsified Medicines Directive (FMD) in Europe, and the Drug Supply Chain Security Act (DSCSA) in the US.

The service means Wasdell can offer serialisation-compliant products globally from its UK-based facilities in Newcastle and Swindon.

The firm’s packaging and testing site​ in Ireland – which is due to open early next year – will also offer serialised products.

Customers can opt for aggreagtion, explained managing director of Wasdell Manufacturing, Daniel Tedham: “Equipping our lines with aggregation capabilities means we are ready to continue supplying products to the US following the 2023 deadline for three-tier parent-child relationships between barcodes and that we can deal with future aments to regulations in other markets.”

According to Tedham, the firm “made the choice to invest in…serialisation capabilities very early on.”

“We wanted to ensure we were ready well ahead of schedule to guarantee that we could effectively support current and future clients with compliance with the EU FMD, US DSCSA and other market regulations,” ​he added.

Just last month​, Wasdell announced plans to invest £500k ($669k) in a 1,200 square-foot laboratory in Newcastle, where it will offer in-house microbiological and analytical services to customers.

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Follow us


View more